Platelet Rich Plasma for Musculoskeletal Conditions
Recruiting · NCT07231471 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Utah
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.
Who can take part
Inclusion criteria
- 18+ years old
- Musculoskeletal pathology that may benefit from a PRP injection
- Failed other conservative treatments
Exclusion criteria
- No active malignancy
- No active infection in the area of injection
- No platelet disorder
- No active systemic infections
- No patients currently undergoing dialysis
Where it is running
1 location listed across 1 US state.
- University of Utah Orthoaedic Center - Salt Lake City, Utah, United States